Back

Natural history, risk stratification and role of antiarrhythmic therapy in arrhythmogenic right ventricular cardiomyopathy

28 August 2016 (14:30 - 14:45)
Organised by:
Congress Presentation Part of: Registries scores and outcomes Cardiomyopathies ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Andrea Mazzanti

University of Pavia, Pavia (Italy)

5 More presentations in this session

Presentation thumbnail
Predictors of 2-year mortality following hospital discharge in patients with acute coronary syndromes: a new risk score from the EPICOR and EPICOR Asia studies
Professor S. Pocock (London, GB)
Slides Video
Presentation thumbnail
Long-term associations between treatment with statins, renin-angiotensin system blockers, beta-blockers and outcome in patients with myocardial infarction with non-obstructive coronary artery disease
Professor B. Lindahl (Uppsala, SE)
Slides Video
Presentation thumbnail
Therapeutic strategies and health costs of patients admitted for an atherothrombotic cardiovascular event in a community setting of nearly 3,000,000 subjects
Doctor A. Maggioni (Florence, IT)
Slides Video
Presentation thumbnail
A Clinical and Biomarker Score for Predicting Presence of Obstructive Coronary Artery Disease: Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA Study).
Professor J. Januzzi (Boston, US)
Slides Video
Presentation thumbnail
Serial biomarkers to identify patients vulnerable for myocardial infarction
Doctor M. Akkerhuis (Rotterdam, NL)

Access the full session

Session thumbnail
Registries scores and outcomes

The Event

Event poster

ESC Congress 2016

28 August 2016 14:30 CET
You may be interested in
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
31 March 2025
thumbnail
Congress Presentation
The utility of the 1994 versus the revised 2010 arrhythmogenic right ventricular cardiomyopathy (ARVC) task force diagnostic criteria for identifying mutation-positive probands with ARVC
28 August 2020
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)
30 March 2025
thumbnail
Congress Presentation
Management and outcomes of patients with refractory arrhythmogenic storm: experience of a tertiary hospital and code shock referral center
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources